“Hormonal Acne: Causes, Patterns, and How to Treat It”

The Pattern That Gives It Away

Hormonal acne has a signature. It tends to concentrate on the lower third of the face: the chin, jawline, and sides of the neck. Breakouts are often deeper and more painful than typical comedonal acne, showing up as cysts or tender papules rather than surface-level blackheads. And there is usually a timing element: flares that track reliably with the menstrual cycle, appearing around ovulation or in the week before menstruation and clearing up once the period begins.

This pattern affects women across a wide age range. Adult female acne, broadly defined as acne persisting or appearing after age 25, affects around 26% of women in their 30s and 12% in their 40s [1]. It is common, often undertreated, and frequently mismanaged with the same approaches used for teenage acne, which do not address the underlying hormonal driver.

Men can also experience hormonally driven acne, particularly during puberty, when anabolic steroid use, or when testosterone therapy causes sebum overproduction. But the condition disproportionately affects adult women, and most of what follows applies specifically to them.

How Hormones Drive Acne

The Role of Androgens

Androgens are the primary hormonal driver of acne. Testosterone, dehydroepiandrosterone sulfate (DHEAS), and dihydrotestosterone (DHT) all stimulate sebaceous glands to produce more sebum. More sebum means more substrate for Cutibacterium acnes bacteria to feed on and more opportunity for pores to become blocked.

The relationship between androgens and acne is not simply about having high testosterone levels. Sebaceous glands are sensitive to even normal circulating androgen levels, and the sensitivity of those glands varies between individuals. This is why many women with hormonal acne have lab values that fall within the normal range: the problem is often at the receptor level or in the local conversion of androgen precursors to DHT within the skin itself [2].

The Menstrual Cycle Connection

Estrogen and progesterone fluctuate across the menstrual cycle in ways that directly influence skin. Estrogen has anti-androgenic properties and reduces sebum production. Progesterone, particularly in its metabolized form, can have pro-androgenic effects on sebaceous glands.

During the luteal phase (the second half of the cycle, after ovulation), progesterone peaks while estrogen drops. This relative shift toward androgens triggers increased sebum production in the days before menstruation. Combined with the fact that skin permeability and inflammation also increase during this phase, it creates conditions ripe for breakouts [3].

Ovulation itself can also trigger flares in some women. The mid-cycle surge in luteinizing hormone (LH) stimulates androgen production in the ovaries, which can tip sebum production upward for a few days around days 12 to 16 of the cycle.

PCOS and Hyperandrogenism

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting 6 to 12% of the population. Hyperandrogenism, one of the three diagnostic criteria for PCOS, manifests as acne, hirsutism (excess facial and body hair), and androgenic alopecia.

Women with PCOS-related acne often experience breakouts that are more severe and more resistant to conventional treatments than typical hormonal acne. This is because the underlying driver is systemic: elevated androgens from the ovaries and adrenal glands, often combined with insulin resistance that further stimulates androgen production [4]. Treating the acne without addressing the PCOS is treating a symptom while ignoring the cause.

Insulin and IGF-1

Insulin and insulin-like growth factor-1 (IGF-1) are less talked about but meaningfully contribute to hormonal acne. Both stimulate sebaceous gland activity and promote the production of androgens in the ovaries and adrenal glands. Diets high in refined carbohydrates and dairy products, which raise insulin and IGF-1, are associated with worse acne in multiple epidemiological studies [5].

This connection explains why adult women with insulin resistance, not just those with PCOS, often struggle with persistent breakouts, and why dietary changes can produce noticeable improvements even without changes to their skincare routine.

Cortisol and Stress

Stress-induced acne flares are real and physiologically explained. The adrenal glands produce androgens, including DHEAS, in response to stress, and cortisol amplifies the sebaceous gland’s sensitivity to those androgens. The skin also has its own local HPA-like axis and can produce corticotropin-releasing hormone (CRH) in response to psychological stress, which directly stimulates sebocytes [6].

Assessing Hormonal Acne

When to Get Labs

Not every woman with cyclical jawline acne needs an endocrine workup. But certain signs warrant investigation: acne that is severe or treatment-resistant, breakouts accompanied by irregular periods, hirsutism, significant hair loss, weight gain, or fatigue. In these cases, testing total and free testosterone, DHEAS, LH, FSH, and fasting insulin and glucose can reveal underlying drivers.

Thyroid dysfunction, particularly hypothyroidism, can also contribute to acne through effects on skin cell turnover and sebum composition. TSH testing is worth including in a comprehensive workup for adult women with persistent acne.

Treatment Options

Oral Contraceptives

Combined oral contraceptives (estrogen plus progestin) treat hormonal acne through two main mechanisms: they suppress ovarian androgen production via LH suppression, and the estrogen component increases sex hormone-binding globulin (SHBG), which binds free testosterone and reduces its availability to sebaceous glands.

Not all OCPs are equally useful for acne. Pills containing progestins with low androgenic activity or anti-androgenic activity are preferred. Drospirenone (found in Yaz, Yasmin, and generics) and cyproterone acetate (not available in the US but widely used elsewhere) are the best-studied options for acne specifically [7]. Three OCP formulations are FDA-approved for acne treatment: Estrostep, Ortho Tri-Cyclen, and Yaz.

OCPs can take three to six months to show full benefit for acne. They are not appropriate for women who smoke and are over 35, who have a history of blood clots, migraines with aura, or certain cardiovascular risk factors.

Spironolactone

Spironolactone is an aldosterone antagonist originally used for heart failure and hypertension. At lower doses (25 to 150 mg per day), it blocks androgen receptors in the skin and reduces androgen-stimulated sebum production. It has become one of the most commonly used off-label treatments for adult female acne in the United States [8].

Clinical evidence supports its effectiveness. A large retrospective study found that 66% of women treated with spironolactone for acne had at least a 50% reduction in lesion count [9]. It is particularly effective for the cystic, deep breakouts along the jawline and chin that characterize hormonal acne.

Side effects include breast tenderness, irregular periods (often improved by combining with an OCP), and, in higher doses, dizziness. Spironolactone is teratogenic in animal studies, so contraception is recommended during use. Potassium levels should be monitored in women with kidney disease, though routine monitoring is generally considered unnecessary in healthy young women on standard doses [10].

Topical Treatments for Hormonal Acne

Topicals play a supporting role in hormonal acne. A topical retinoid (adapalene, tretinoin) addresses the comedonal component and keeps pores clear. Azelaic acid is particularly useful for women who also deal with post-inflammatory hyperpigmentation, which is common in adult women with deeper skin tones.

Topical clascoterone (Winlevi) is a newer option worth knowing about. It is a topical androgen receptor antagonist that blocks DHT at the level of the sebaceous gland without systemic hormonal effects. In clinical trials, it reduced inflammatory and non-inflammatory acne lesion counts comparably to tretinoin 0.025%, making it an option for women who cannot use or do not want systemic hormonal treatments [11].

Dietary and Lifestyle Approaches

Reducing dietary glycemic load is the most evidence-backed dietary intervention for acne. A randomized controlled trial found that a low-glycemic diet led to significant reductions in acne lesion counts over 12 weeks, alongside reductions in free androgen index [12]. Reducing dairy, particularly skimmed milk (which paradoxically has a higher acne association than whole milk, likely due to whey protein and growth factor content), is also supported by observational data.

For women with PCOS, inositol supplements, particularly myo-inositol at 2 to 4 grams per day, improve insulin sensitivity and reduce androgen levels. Several trials have shown improvements in acne alongside improvements in cycle regularity and hormonal markers [13].

Sleep, exercise, and stress management all matter here in ways that are not trivial. Chronic sleep deprivation raises cortisol and insulin, both of which worsen hormonal acne. High-intensity exercise (particularly appropriate amounts, not overtraining) improves insulin sensitivity. And whatever stress management practices a person will actually sustain, whether therapy, meditation, or simply protecting sleep and downtime, has measurable effects on hormonal balance.

Nutraceuticals with Evidence

Zinc, particularly oral zinc gluconate or zinc acetate, has meaningful anti-inflammatory and mild anti-androgenic effects. Multiple trials have shown reductions in acne lesion counts, though it tends to perform less well than oral antibiotics in direct comparisons. It is a reasonable option for women who prefer to minimize pharmaceutical drug exposure [14].

DIM (diindolylmethane), a compound derived from cruciferous vegetables, promotes the metabolism of estrogen toward less potent forms and has a modest influence on androgen metabolism. Clinical evidence for DIM specifically in acne is limited, but it is low-risk and popular in functional medicine settings for hormonally driven skin issues.

A Note on Perimenopause and Postmenopausal Acne

Acne during perimenopause is common and often surprises women who expect their skin to clear as they get older. As estrogen levels decline and fluctuate, the relative androgenic effect on sebaceous glands increases. Progesterone loss also removes some of the counterbalancing effects on skin inflammation.

Postmenopausal acne, though less common, does occur. In these cases, the ratio of androgens to estrogen is even more skewed, and low-dose topical estrogens, spironolactone, or retinoids may all play a role in management. A gynecologist or dermatologist familiar with hormonal skin changes is worth consulting for acne that develops or worsens during this transition.

Related Reading

• Acne Treatment Options: From Topicals to Regenerative Therapies
• What Causes Acne? The Science Behind Breakouts
• Severe Acne Treatment: Options Beyond Accutane
• Peptide Injections: What They Are and How They Work
• Red Light Therapy at Home

References

1. Dreno B et al. “Acne in women: a real-world study with dermatologist’s evaluation.” Int J Dermatol. 2019;58(3):e37-e38. doi:10.1111/ijd.14176
2. Deplewski D, Rosenfield RL. “Role of hormones in pilosebaceous unit development.” Endocr Rev. 2000;21(4):363-392. doi:10.1210/edrv.21.4.0404
3. Thiboutot D, Gilliland K, Light J, Lookingbill D. “Androgen metabolism in sebaceous glands from subjects with and without acne.” Arch Dermatol. 1999;135(9):1041-1045. doi:10.1001/archderm.135.9.1041
4. Nestler JE. “Metformin for the treatment of the polycystic ovary syndrome.” N Engl J Med. 2008;358(1):47-54. doi:10.1056/NEJMct0707092
5. Adebamowo CA et al. “High school dietary dairy intake and teenage acne.” J Am Acad Dermatol. 2005;52(2):207-214. doi:10.1016/j.jaad.2004.08.007
6. Zouboulis CC, Bohm M. “Neuroendocrine regulation of sebocytes: a pathogenetic link between stress and acne.” Exp Dermatol. 2004;13(Suppl 4):31-35. doi:10.1111/j.1600-0625.2004.00254.x
7. Koltun W et al. “Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 microg plus drospirenone 3 mg administered in a 24/4 regimen: a pooled analysis.” Eur J Obstet Gynecol Reprod Biol. 2011;155(2):171-175. doi:10.1016/j.ejogrb.2010.12.027
8. Charny JW, Choi JK, James WD. “Spironolactone for the treatment of acne in women, a retrospective study of 110 patients.” Int J Womens Dermatol. 2017;3(2):111-115. doi:10.1016/j.ijwd.2016.12.002
9. Swinnen I, Declercq L, Garmyn M. “Topical androgen receptor antagonist for the treatment of acne and seborrhoea.” Eur J Dermatol. 2007;17(3):227-229.
10. Plovanich M, Weng QY, Mostaghimi A. “Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne.” JAMA Dermatol. 2015;151(9):941-944. doi:10.1001/jamadermatol.2015.0454
11. Hebert AA et al. “Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials.” JAMA Dermatol. 2020;156(6):621-630. doi:10.1001/jamadermatol.2020.0465
12. Smith RN, Mann NJ, Braue A, Makelainen H, Varigos GA. “The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial.” J Am Acad Dermatol. 2007;57(2):247-256. doi:10.1016/j.jaad.2007.01.046
13. Zacche MM, Caputo L, Filippis S, Zacche G, Dindelli M, Ferrari A. “Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.” Gynecol Endocrinol. 2009;25(8):508-513. doi:10.1080/09513590903015544
14. Dreno B et al. “Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris.” Dermatology. 2001;203(2):135-140. doi:10.1159/000051728